Statistics for REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
Total visits
| views | |
|---|---|
| REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal | 22 |
Total visits per month
| views | |
|---|---|
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Batista-2021-Realms-study-real-world-effectivene.pdf | 6 |
| Batista-2021-Realms-study-real-world-effectivene.pdf(legacy) | 4 |
Top country views
| views | |
|---|---|
| United States | 9 |
| Australia | 4 |
| Canada | 3 |
| China | 2 |
| United Kingdom | 1 |
| Mongolia | 1 |
| Norway | 1 |
| Portugal | 1 |